Manulife appoints HyounJoo Choe as Chief Customer Officer for Hong Kong and Macau to spearhead customer experience and centricity
HONG KONG, Sept. 13, 2022 /PRNewswire/ -- Manulife Hong Kong today announced the appointment of HyounJoo Choe as Chief Customer Officer, Hong Kong and Macau. As a member of the senior management team, Ms Choe will lead all customer experience and strategic marketing functions including marketing, customer relationship management, advanced analytics, insights and corporate communications. She will also play a...
Chinese NMPA Approves Pivotal Phase III Study of TLX591-CDx for Prostate Cancer Imaging
MELBOURNE, Australia, Oct. 17, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the Chinese National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE) has approved an investigational new drug (IND) application to commence a pivotal Phase III registration study of TLX591-CDx (Kit for the preparation of...
Third Time’s a Charm: Hisense Extends Strategic Partnership with UEFA to Sponsor EURO 2024
BERLIN, Sept. 1, 2023 /PRNewswire/ -- Global consumer electronics and appliances corporation Hisense has announced that it has signed as a global sponsor of UEFA EURO 2024™. This will mark the third consecutive UEFA EURO that Hisense will sponsor after being a partner for the two previous editions and a successful sponsorship of FIFA World Cup 2022™. Hisense will...
Archipelago Publishes Travel Agent Rates for Cuba Hotels
Offering Special Rates and Unbeatable Vacations in Several Holiday Destinations SANTA CLARA, Cuba, Feb. 4, 2022 /PRNewswire/ -- Archipelago, Southeast Asia's largest private and independent hotel management group, invites international travelers to take their long-awaited holidays in Cuba. To support the growth of the tourism industry in Cuba and introduce their upcoming...
OSR Holdings Appoints Dr. Andreas Niethammer as Chief Medical Officer of Vaximm AG, an OSR Company
BASEL, Switzerland and SEOUL, South Korea, July 15, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company dedicated to advancing healthcare outcomes and improving the quality of life for people and their families, today announced the appointment of Dr Andreas Niethammer, M.D., Ph.D., as Chief Medical Officer of Vaximm AG, an OSR Company developing a platform of...
Everest Medicines’ Licensing Partner Pfizer Announces FDA and EMA Acceptance of Etrasimod Regulatory Submissions for Ulcerative Colitis
SHANGHAI, Dec. 22, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK) announced today that its licensing partner, Pfizer Inc. (NYSE: PFE) has received acceptance from the U.S. Food and Drug Administration (FDA) for review a New Drug Application (NDA) for etrasimod for individuals living with moderately-to-severely active ulcerative colitis (UC). The FDA's decision is expected in the second half of...
Official Announcement by Ampace: Introducing the BP System and “Kun-Era” Battery, Paving the Way for a New Era in Global Energy Transformation from Fuel to Electricity
CHONGQING, China, Sept. 16, 2023 /PRNewswire/ -- On September 15, Xiamen Ampace Technology Limited (hereinafter referred to as "Ampace"), a company renowned for its commitment to pioneering lithium battery research and innovation, marked its inaugural presence at the 21st China International Motorcycle Trade Exhibition (CIMAMotor 2023 for short). During this significant event, Ampace has unveiled two changing offerings: the revolutionary...
Kazia Therapeutics Highlights New Clinical and Translational Findings Demonstrating Paxalisib’s Ability to Reinvigorate Anti-Tumor Immunity Across Multiple Advanced Breast Cancer Populations including TNBC and HER2+
First patient from TNBC trial demonstrated 76% tumor volume shrinkage with corresponding reductions in circulating tumor cells (CTC) and clusters Reinvigoration of immune system + turning cold tumors hot Preliminary ex-vivo data in HER2+ patients demonstrates immune reinvigoration and reductions in CTC and clusters SYDNEY, Dec. 10, 2025 /PRNewswire/ -- Kazia Therapeutics Limited ("Kazia" or the "Company") (NASDAQ: KZIA) today...
Proprietary SARS-CoV-2 3CL Inhibitor Rapidly Progressing in Clinical Trials, Market Approval of Trilaciclib Expected in China, Simcere Reveals Global Innovation Ambition on R&D Day
NANJING, China, April 19, 2022 /PRNewswire/ -- On April 15, 2022, Simcere Pharmaceutical (2096.HK), an innovation and R&D driven pharmaceutical company in China held its first R&D day for international investors, during which the executive leaders revealed Simere's R&D strategy, and gave an update on Simcere's pipeline to the global investment community. Mr. REN Jinsheng, Chairman and CEO, Dr. TANG...
Australia takes centre stage as a cure for Rett Syndrome draws closer
GOLD COAST, Australia, Oct. 2, 2024 /PRNewswire/ -- Australian researcher Associate Professor Wendy Gold, a world leader in Rett Syndrome research from the University of Sydney, joins international colleagues and Rett families on the Gold Coast today to present the latest advances toward a cure.  What is Rett Syndrome? Associate Professor Wendy Gold explains....
- Advertisement -
